Supernus Pharmaceuticals | SUPN - Actif À Court Terme





Actif À Court Terme Changement Date
Abbott USD 26B 1.16B 2025-12
ANI Pharmaceuticals USD 753.12M 54.72M 2025-12
Aurora Cannabis CAD 445.84M 22M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Canopy Growth CAD 524.67M 78.85M 2025-12
Cara Therapeutics USD 43.13M 4.18M 2025-06
Corcept Therapeutics USD 485.46M 55.67M 2025-12
Eisai JPY 840.88B 50.18B 2025-12
Eli Lilly USD 55.63B 6.44B 2025-12
Novo Nordisk DKK 172.45B 9.43B 2025-12
Pacira USD 547.97M 14.78M 2025-12
Perrigo USD 2.8B 81.8M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Supernus Pharmaceuticals USD 644.18M 50.29M 2025-12
United Therapeutics USD 3.7B 208.5M 2025-12
Xeris Pharmaceuticals USD 240.31M 16.3M 2025-12